S&P 500   4,254.11 (+0.58%)
DOW   33,099.55 (+0.29%)
QQQ   358.54 (+1.02%)
AAPL   173.04 (+0.37%)
MSFT   318.18 (+1.53%)
META   305.59 (+1.55%)
GOOGL   134.99 (+1.93%)
AMZN   126.02 (+1.04%)
TSLA   256.53 (+4.06%)
NVDA   439.04 (+0.89%)
NIO   8.74 (+1.51%)
BABA   84.19 (-0.41%)
AMD   102.30 (+2.22%)
T   14.56 (-1.49%)
F   12.05 (-0.17%)
MU   67.75 (-0.12%)
CGC   0.76 (+11.96%)
GE   108.85 (+1.01%)
DIS   79.31 (-0.29%)
AMC   8.05 (+2.55%)
PFE   33.61 (-0.86%)
PYPL   58.26 (+1.68%)
NFLX   379.00 (+0.60%)
S&P 500   4,254.11 (+0.58%)
DOW   33,099.55 (+0.29%)
QQQ   358.54 (+1.02%)
AAPL   173.04 (+0.37%)
MSFT   318.18 (+1.53%)
META   305.59 (+1.55%)
GOOGL   134.99 (+1.93%)
AMZN   126.02 (+1.04%)
TSLA   256.53 (+4.06%)
NVDA   439.04 (+0.89%)
NIO   8.74 (+1.51%)
BABA   84.19 (-0.41%)
AMD   102.30 (+2.22%)
T   14.56 (-1.49%)
F   12.05 (-0.17%)
MU   67.75 (-0.12%)
CGC   0.76 (+11.96%)
GE   108.85 (+1.01%)
DIS   79.31 (-0.29%)
AMC   8.05 (+2.55%)
PFE   33.61 (-0.86%)
PYPL   58.26 (+1.68%)
NFLX   379.00 (+0.60%)
S&P 500   4,254.11 (+0.58%)
DOW   33,099.55 (+0.29%)
QQQ   358.54 (+1.02%)
AAPL   173.04 (+0.37%)
MSFT   318.18 (+1.53%)
META   305.59 (+1.55%)
GOOGL   134.99 (+1.93%)
AMZN   126.02 (+1.04%)
TSLA   256.53 (+4.06%)
NVDA   439.04 (+0.89%)
NIO   8.74 (+1.51%)
BABA   84.19 (-0.41%)
AMD   102.30 (+2.22%)
T   14.56 (-1.49%)
F   12.05 (-0.17%)
MU   67.75 (-0.12%)
CGC   0.76 (+11.96%)
GE   108.85 (+1.01%)
DIS   79.31 (-0.29%)
AMC   8.05 (+2.55%)
PFE   33.61 (-0.86%)
PYPL   58.26 (+1.68%)
NFLX   379.00 (+0.60%)
S&P 500   4,254.11 (+0.58%)
DOW   33,099.55 (+0.29%)
QQQ   358.54 (+1.02%)
AAPL   173.04 (+0.37%)
MSFT   318.18 (+1.53%)
META   305.59 (+1.55%)
GOOGL   134.99 (+1.93%)
AMZN   126.02 (+1.04%)
TSLA   256.53 (+4.06%)
NVDA   439.04 (+0.89%)
NIO   8.74 (+1.51%)
BABA   84.19 (-0.41%)
AMD   102.30 (+2.22%)
T   14.56 (-1.49%)
F   12.05 (-0.17%)
MU   67.75 (-0.12%)
CGC   0.76 (+11.96%)
GE   108.85 (+1.01%)
DIS   79.31 (-0.29%)
AMC   8.05 (+2.55%)
PFE   33.61 (-0.86%)
PYPL   58.26 (+1.68%)
NFLX   379.00 (+0.60%)
NASDAQ:CELZ

Creative Medical Technology (CELZ) Stock Forecast, Price & News

$4.73
-0.02 (-0.42%)
(As of 11:48 AM ET)
Compare
Today's Range
$4.71
$4.85
50-Day Range
$4.23
$6.16
52-Week Range
$3.30
$14.20
Volume
2,310 shs
Average Volume
175,464 shs
Market Capitalization
$6.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CELZ stock logo

About Creative Medical Technology (NASDAQ:CELZ) Stock

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

CELZ Price History

CELZ Stock News Headlines

[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
See More Headlines
Receive CELZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creative Medical Technology and its competitors with MarketBeat's FREE daily newsletter.

CELZ Company Calendar

Last Earnings
8/11/2023
Today
10/04/2023
Next Earnings (Estimated)
11/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CELZ
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Net Income
$-10,140,000.00
Pretax Margin
-12,637.84%

Debt

Sales & Book Value

Annual Sales
$90,000.00
Book Value
$11.27 per share

Miscellaneous

Free Float
1,369,000
Market Cap
$6.70 million
Optionable
Not Optionable
Beta
2.47
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Timothy Warbington (Age 61)
    Co-Founder, Chairman, Pres & CEO
    Comp: $429k
  • Mr. Donald Dickerson (Age 58)
    Sr. VP, CFO & Director
    Comp: $390k













CELZ Stock - Frequently Asked Questions

How have CELZ shares performed in 2023?

Creative Medical Technology's stock was trading at $3.8110 at the beginning of the year. Since then, CELZ shares have increased by 24.6% and is now trading at $4.75.
View the best growth stocks for 2023 here
.

Are investors shorting Creative Medical Technology?

Creative Medical Technology saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 89,800 shares, an increase of 297.3% from the August 31st total of 22,600 shares. Based on an average trading volume of 55,300 shares, the days-to-cover ratio is presently 1.6 days. Currently, 6.4% of the shares of the company are short sold.
View Creative Medical Technology's Short Interest
.

When is Creative Medical Technology's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, November 10th 2023.
View our CELZ earnings forecast
.

How were Creative Medical Technology's earnings last quarter?

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) released its earnings results on Friday, August, 11th. The company reported ($0.78) EPS for the quarter, topping analysts' consensus estimates of ($0.83) by $0.05.

When did Creative Medical Technology's stock split?

Creative Medical Technology shares reverse split before market open on Sunday, June 11th 2023. The 1-10 reverse split was announced on Sunday, June 11th 2023. The number of shares owned by shareholders was adjusted after the market closes on Sunday, June 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What is Creative Medical Technology's stock symbol?

Creative Medical Technology trades on the NASDAQ under the ticker symbol "CELZ."

How do I buy shares of Creative Medical Technology?

Shares of CELZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Creative Medical Technology's stock price today?

One share of CELZ stock can currently be purchased for approximately $4.75.

How much money does Creative Medical Technology make?

Creative Medical Technology (NASDAQ:CELZ) has a market capitalization of $6.70 million and generates $90,000.00 in revenue each year.

How can I contact Creative Medical Technology?

Creative Medical Technology's mailing address is 2017 W Peoria Ave, PHOENIX, AZ 85029-4916, United States. The official website for the company is www.creativemedicaltechnology.com. The company can be reached via phone at (833) 336-7636 or via email at kahl@equityny.com.

This page (NASDAQ:CELZ) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -